# Peptides in 2 — Episode 12: Zenagamtide / Amycretin

Revised review cut. One peptide, complementary signals. Evidence cutoff: October 13, 2026. Published October 14, 2026.

Exactly 2:00, 1920×1080, 24 fps. The four liked images are preserved. One continuous Tom voice performance covers content and closing; the older closing recordings are removed. Generation speed is 0.85 and post-production voice tempo is 1.0. A shorter script gives the opening room to breathe. The instrumental score is retained at a restrained level.

## Measured sequence

| Seconds | Visual |
|---|---|
| 0.00–2.00 | WPF opening |
| 2.00–14.14 | Retained synthesis instrument image |
| 14.14–26.92 | Regional maps: Denmark and Texas |
| 26.92–44.70 | Coordinate-based receptor architecture; slow camera orbit |
| 44.70–61.68 | Retained oral formulation image; participant counts |
| 61.68–78.76 | Complete exact HbA1c intervals |
| 78.76–93.24 | Retained clinical instrument image; safety context |
| 93.24–109.30 | Retained beamline image; development status |
| 109.30–120.00 | WPF closing; same continuous narrator |

Scene boundaries follow measured speech. The opening narration runs at approximately 108 words per minute. Speech finishes around 114.5 seconds, leaving a quiet branded hold before the 119.5-second picture fade.

## Scientific and visual controls

Replace the globe with regional maps. Replace the bead motif with coordinate-based GLP-1R and AMY2 receptor architecture, using new sources 6KJV and 7TYX. The camera moves slowly; no binding animation or molecular dynamics is implied. These structures do not show zenagamtide. Full coordinate provenance and omitted components are documented in Behind the Film.

The clinical intervals show dose-group mean estimate ranges, not confidence intervals, individual responses or route superiority. The two route analyses remain distinct. The developer, investigators, affiliations and study locations have separate credits. The four conceptual technology images appear once each.

## Materials and validation

Published MP4, reproducible source pack, plan, transcript, recognition-timed SRT/VTT captions, thumbnail and detailed evidence notes. Verify full decode, continuous narration throughout all eight speech windows, complete closing, exact runtime and format, caption bounds, retained artwork and model motion. No paid video generation.